Volition announces clinical validation for Nu.Q NETs biomarker in sepsis
Volition (VNRX) said clinical validation of its Nu.Q NETs biomarker in sepsis has been announced.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.